Immutep (IMMP) Total Debt (2012 - 2025)

Immutep's (IMMP) quarterly Total Debt came in at $330323.8 in Q4 2025, down 78.1% quarter-over-quarter from $1.5 million in Q4 2015.

Analysis

Immutep (IMMP) Total Debt (2012 - 2025) Analysis & Trends

Immutep (IMMP) has reported Total Debt for 5 consecutive years, with $330323.8 the latest figure, recorded in Q4 2025.

For the quarter ending Q4 2025, Total Debt changed N/A year-over-year to $330323.8; the trailing twelve-month figure through Dec 2025 stood at $330323.8 (changed N/A YoY), and the FY2015 full-year result was $1.3 million, changed N/A from the prior year.
Total Debt eased to $330323.8 in Q4 2025 per IMMP's latest filing, from $1.5 million in the prior quarter.
Across five years, Total Debt topped out at $330323.8 in Q4 2025 and bottomed at $330323.8 in Q4 2025.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Debt (Qtr)
1	Amgen	211.73 Bn	197.74 Bn	7.24 Bn	62.75 Bn
2	Gilead Sciences	180.92 Bn	177.74 Bn	6.22 Bn	28.66 Bn
3	Vertex Pharmaceuticals	132.16 Bn	124.30 Bn	2.84 Bn	-
4	Regeneron Pharmaceuticals	82.89 Bn	74.90 Bn	3.93 Bn	1.99 Bn
5	Argenx Se	61.41 Bn	56.23 Bn	1.37 Bn	-
6	Moderna	53.99 Bn	48.85 Bn	52.00 Mn	591.00 Mn
7	Alnylam Pharmaceuticals	34.48 Bn	31.18 Bn	992.69 Mn	-
8	Biogen	31.15 Bn	29.86 Bn	1.96 Bn	8.09 Bn
9	Roivant Sciences	30.05 Bn	30.05 Bn	1.16 Mn	-
10	Immutep	51.68 Mn	51.68 Mn	-	-

Historic Data

Download Data